Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Aptevo Therapeutics Inc.(APVO US)

$1.61+0.000.00%Ext:$1.35-0.2616.36%(Market Closed · 23:47:19 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
APVO US​

Financials

Income StatementBalance Sheet

Cash Flow

Millions USD (ex. Per Share)
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-17.4-24.1-26.0-26.3
Depreciation & Amortization0.60.40.20.2
Stock Based Compensation2.21.10.1-0.0
Change in Working Capital2.9-1.1-1.1-2.3
Other Non-Cash Items0.0-1.12.9
Net Cash from Operating Activities-11.7-23.8-25.6-27.0
-Investments in Property, Plant & Equipment----
-Acquisitions Net----
-Purchases of Investments----
Sales/Maturities of Investments----
Other Investing Activities----
Net Cash from Investing Activities----
Net Debt Issuance-3.5---
Net Stock Issuance6.410.038.538.8
-Net Dividends Paid----
Other Financing Activities3.05.6-0.6
Net Cash from Financing Activities6.015.638.539.4
Effect of Forex Changes----
Net Change in Cash-5.7-8.212.912.4
Cash at End of Period16.98.721.666.6
Operating Cash Flow-11.7-23.8-25.6-27.0
-Capital Expenditure----
Free Cash Flow-11.7-23.8-25.6-27.0